Marie H. Robin
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 329 publications
Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone-a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT.
Journal: Bone marrow transplantation
Published: April 15, 2026
Demodex-associated dermatoses after allogeneic HSCT: A retrospective multicentre study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 15, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 27, 2026
Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT.
Journal: American journal of hematology
Published: March 09, 2026
CPX-351 before allogeneic stem cell transplantation, a real-world French experience.
Journal: Haematologica
Published: March 06, 2026
Pesticide-free agriculture: Is a third way possible besides organic and conventional agriculture?
Journal: Plant disease
Published: February 18, 2026
Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.
Journal: American journal of hematology
Published: February 03, 2026
Allogeneic haematopoietic stem cell transplantation in myelofibrosis: Patient selection, pre-transplant preparation and harmonisation of practices (SFGM-TC)
Journal: Bulletin du cancer
Published: January 28, 2026
Risk of Posttransplant Cyclophosphamide-related Cardiotoxicity in Allogeneic Stem Cell Transplantation.
Journal: The Canadian journal of cardiology
Published: January 26, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee.
Journal: The Lancet. Haematology
Published: January 12, 2026
PTCy or ATG for Matched Transplantation in Myelofibrosis.
Journal: American journal of hematology
Published: January 03, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.
Journal: Bone marrow transplantation
Published: November 30, 2025
Last Updated: 09/26/2026